GSK plc (GLAXF) stock
GLAXFOTCPharmaceutical PreparationsAlso trades as GSK
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$24.74+0.30 (+1.21%)
Close on Oct 19, 2026Market cap $106.83BP/E 13.3Yield –
GSK operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was 24.3%, against 12.8% the year before. The highest annual figure on record is 43.1% in fiscal 2015.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 24.3% | +11.5 |
| FY2024 | Dec 31, 2024 | 12.8% | −9.4 |
| FY2023 | Dec 31, 2023 | 22.2% | +0.3 |
| FY2022 | Dec 31, 2022 | 21.9% | +4.3 |
| FY2021 | Dec 31, 2021 | 17.6% | −6.9 |
| FY2020 | Dec 31, 2020 | 24.6% | +3.9 |
| FY2019 | Dec 31, 2019 | 20.6% | +2.8 |
| FY2018 | Dec 31, 2018 | 17.8% | +4.3 |
| FY2017 | Dec 31, 2017 | 13.5% | +4.2 |
| FY2016 | Dec 31, 2016 | 9.3% | −33.8 |
| FY2015 | Dec 31, 2015 | 43.1% | – |